TORONTO, ONTARIO–(Marketwired – Jan. 9, 2018) – Uranium Participation Corporation (“UPC”) (TSX:U) reports its estimated net asset value at December 31, 2017 was CAD6.0 million or CAD.82 per share. As at December 31, 2017, UPC’s uranium investment portfolio consisted of the following:

On December 31, 2017, the common shares of UPC closed on the TSX at a value of CAD.23, which represents a 10.73% premium to the net asset value of CAD.82 per share.

On October 4, 2017, UPC issued 11,600,000 common shares for total gross proceeds of ,600,000 in a bought-deal equity offering intended to fund purchases of uranium and for general corporate purposes.

During the month of December 2017, the Corporation completed the purchase of an additional 630,000 pounds U₃O₈ at an average cost of US.53 (CAD.32) per pound U₃O₈. In total, the Corporation has purchased 1,350,000 pounds U₃O₈ at an average cost of US.40 (CAD.90) per pound U₃O₈ with the proceeds of the October 2017 financing.

About Uranium Participation Corporation

Uranium Participation Corporation is a company that invests substantially all of its assets in uranium oxide in concentrates (“U₃O₈“) and uranium hexafluoride (“UF₆“) (collectively “uranium”), with the primary investment objective of achieving appreciation in the value of its uranium holdings through increases in the uranium price. UPC provides investors with a unique opportunity to gain exposure to the price of uranium without the resource or project risk associated with investing in a traditional mining company. Additional information about Uranium Participation Corporation is available on SEDAR at www.sedar.com and on Uranium Participation Corporation’s website at www.uraniumparticipation.com.

Caution Regarding Forward-Looking Information

This press release contains certain forward-looking statements and forward-looking information that are based on the Company’s current internal expectations, estimates, projections, assumptions and beliefs. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intent”, “estimate”, “anticipate”, “plan”, “should”, “believe” or “continue” or the negative thereof or variations thereon or similar terminology and include statements with respect to the use of proceeds for the Offering and the anticipated completion of uranium purchases.

By their very nature, forward-looking statements involve numerous factors, assumptions and estimates. A variety of factors, many of which are beyond the control of the Company, may cause actual results to differ materially from the expectations expressed in the forward-looking statement. These factors include, but are not limited to, changes in commodity prices and foreign exchange as well as the risk that the Company will not be successful in completing the purchase of additional U₃O₈ and/or UF₆ on terms satisfactory to the Company. For a description of the principal risks of the Company, see “Risk Factors” in the Company’s Annual Information Form dated May 16, 2017, a copy of which is available at www.sedar.com.

These and other factors should be considered carefully, and readers are cautioned not to place undue reliance on these forward-looking statements. Although management reviews the reasonableness of its assumptions and estimates, unusual and unanticipated events may occur which render them inaccurate. Under such circumstances, future performance may differ materially from those expressed or implied by the forward-looking statements. Except where required under applicable securities legislation, the Company does not undertake to update any forward-looking information statement.